| Drug Name: | Propylthiouracil (51-52-5) |
|---|---|
| PubChem ID: | 657298 |
| SMILES: | CCCC1=CC(=O)NC(=S)N1 |
| InchiKey: | KNAHARQHSZJURB-UHFFFAOYSA-N |
| Therapeutic Category: | Antimetabolites, Antithyroid Agents, Hormone Antagonists, Hormones, Noxae |
| Molecular Weight (dalton) | : | 170.237 |
| LogP | : | 1.38499 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 48.65 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Vasculitis | anti-neutrophil cytoplasmic antibody (ANCA) (P00002) | Propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) [ ADR Type 5 ] | Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category